MaxCyte, Inc. (MXCT)
0.8478
+0.03
(+3.99%)
USD |
NASDAQ |
Apr 17, 16:00
0.8515
0.00 (0.00%)
After-Hours: 20:00
MaxCyte Research and Development Expense (Quarterly) : 3.335M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| TELA Bio, Inc. | 2.129M |
| CONMED Corp. | 14.90M |
| Dynatronics Corp. | -- |
| Escalon Medical Corp. | 0.1312M |
| IRIDEX Corp. | 0.949M |